Nutritional Approach in Pediatric Patients with Inflammatory Bowel Disease: Treatment, Risk and Challenges
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Nutritional interventions are crucial for pediatric Inflammatory Bowel Diseases (IBD). Exclusive enteral nutrition (EEN) effectively induces remission in pediatric Crohn
Area Of Science
- Pediatric Gastroenterology and Nutrition
- Inflammatory Bowel Disease (IBD) Management
Background
- Pediatric Inflammatory Bowel Diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), pose unique challenges such as growth impairment and psychosocial difficulties.
- Nutritional interventions are a cornerstone of pediatric IBD management, complementing advanced biologic and targeted therapies.
Purpose Of The Study
- To review current evidence on nutritional strategies for managing pediatric IBD.
- To highlight the therapeutic potential and limitations of various dietary interventions.
- To emphasize the integration of nutrition with pharmacologic treatment in a multidisciplinary approach.
Main Methods
- Narrative review of existing literature on nutritional interventions in pediatric IBD.
- Analysis of studies evaluating exclusive enteral nutrition (EEN), modified diets (e.g., Crohn's Disease Exclusion Diet - CDED), and general dietary patterns.
Main Results
- Exclusive enteral nutrition (EEN) is a first-line therapy for inducing remission in pediatric Crohn's disease, with efficacy comparable to corticosteroids and added benefits for mucosal healing and growth.
- Modified dietary approaches like partial enteral nutrition and CDED show promise for improving adherence and remission maintenance in pediatric CD.
- The role of nutrition in ulcerative colitis is less defined, but anti-inflammatory diets may be beneficial.
Conclusions
- Nutritional strategies, particularly EEN, are vital for inducing remission and improving outcomes in pediatric Crohn's disease.
- Individualized, dietitian-supervised nutritional care is essential to mitigate risks of deficiencies and psychosocial stress associated with dietary restrictions.
- A multidisciplinary approach integrating nutritional support with pharmacologic treatments is key to optimizing quality of life for children with IBD.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Strictureplasty
Proctocolectomy or total colectomy with ileostomy
Restorative proctocolectomy with Ileal pouch-anal anastomosis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...